DiaMedica Therapeutics (DMAC) Property, Plant & Equipment (Net) (2017 - 2026)
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.13 Bn | 193.14 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 179.53 Bn | 176.35 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 131.46 Bn | 123.61 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 81.89 Bn | 73.90 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 61.12 Bn | 55.94 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 53.31 Bn | 48.17 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 33.36 Bn | 30.05 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.72 Bn | 30.43 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 29.32 Bn | 29.32 Bn | 1.16 Mn | 11.32 Mn |
| 10 | DiaMedica Therapeutics | 346.00 Mn | 346.00 Mn | - | 133,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133,000.00 |
| Mar 31, 2026 | 142,000.00 |
| Dec 31, 2025 | 145,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 152,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 152,000.00 |
| Mar 31, 2024 | 132,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Sep 30, 2023 | 135,000.00 |
| Jun 30, 2023 | 133,000.00 |
| Mar 31, 2023 | 136,000.00 |
| Dec 31, 2022 | 136,000.00 |
| Sep 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Sep 30, 2021 | 70,000.00 |